高血压患者的家族性高胆固醇血症:中国H型高血压登记研究
Tianzhou Shen1, Renfei Luo1, Hongdong Jiang2
1Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Lipids in health and disease
|March 27, 2025
概括
家庭性高胆固醇血症 (FH) 在农村高血压患者中很常见,但未得到充分治疗. 提高意识和治疗对于管理动脉样硬化心血管疾病 (ASCVD) 风险至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 家族性高胆固醇血症 (FH) 显著增加了动脉样硬化心血管疾病 (ASCVD) 的风险.
- 高血压是一种常见的并发症,可能会加剧FH患者的心血管风险.
- 了解农村高血压患者等特定人群中的FH患病率对于有针对性的干预至关重要.
研究的目的:
- 确定FH在中国农村高血压人口中的患病率和临床特征.
- 评估该队列内的FH患者的管理和LDL-C降低.
- 为了评估ASCVD风险因素和结果在高血压的个体和没有FH.
主要方法:
- 一项前性观察队列研究 (中国H型高血压注册研究) 招募了14234名农村高血压患者.
- 用中国修改的荷兰脂质临床网络 (C-DLCN) 标准来诊断FH.
- 在4年的随访期间收集了人口统计,临床特征,降脂疗法和心血管事件的数据.
主要成果:
- 在10900名分析患者中,0.72%的人可能或确定的FH.
- 只有35.9%的FH患者接受了降脂疗法,3.6%的人达到LDL-C目标.
- 尽管基线ASCVD风险较高,但在4年后,在FH和非FH组之间没有观察到中风或心血管疾病事件率的显著差异.
结论:
- 在农村高血压人口中,FH患病率和治疗率之间存在很大的差距.
- 需要提高FH的认识和管理,特别是在具有并存风险因素的个体中.
- 需要进一步的研究,以优化ASCVD风险降低策略的FH患者在初级保健设置.
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:28Hypertension I: Introduction
1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
01:29Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
886
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K